12 Biggest Mid-Day Gainers For Tuesday

Navidea Biopharmaceuticals Inc NAVB shares climbed 79 percent to $0.611 as the company announced a Letter of Intent to sell Lymphoseek in North America to Cardinal Health Inc CAH.
CoLucid Pharmaceuticals Inc CLCD shares jumped 77.7 percent to $18.94 after the company disclosed that its SAMURAI final stage study evaluating lasmiditan achieved both the primary and key secondary efficacy endpoints. The company claimed that lasmiditan was well tolerated.
Cepheid CPHD shares climbed 51.8 percent to $52.25. Danaher Corporation DHR disclosed Tuesday that it reached a definitive merger deal with Cepheid to buy the latter for $53.00 a share in cash.
Navistar International Corp NAV shares jumped 50.7 percent to $21.20. Navistar disclosed it established a wide-ranging strategic alliance with Volkswagen Truck & Bus. As a result, the company would get an investment of $256 million from Volkswagen at $15.76 a share. This would translate into 16.6 percent stake.
Dynavax Technologies Corporation DVAX shares surged 26.7 percent to $13.82. Dynavax confirmed the cancellation of November 16, 2016 FDA VRBPAC meeting. The company said that PDUFA date of December 15, 2016 for HEPLISAV-B remains unchanged.
Nova Lifestyle Inc NVFY shares rose 22.4 percent to $1.53. Nova Lifestyle shares have dropped 42.66 percent over the past 52 weeks, while the S&P 500 index has gained 10.69 percent in the same period.
Burcon NutraScience Corp BUR gained 20.4 percent to $2.62 as the company disclosed that Archer Daniels Midland Company ADM confirmed plans to achieve full commercial production of CLARISOY soy protein this year.
Spectra Energy Corp. SE climbed 13.1 percent to $40.90. Enbridge and Spectra Energy agreed to merge in an all-stock transaction.
Paramount Gold Nevada Corp PZG shares rose 11.1 percent to $2.11. Gold futures gained 1.32 percent to trade at $1,344.20 an ounce.
Threshold Pharmaceuticals, Inc. THLD shares gained 9.1 percent to $1.32 in pre-market trading after surging 15.24 percent on Friday.
Enbridge Inc (USA) ENB shares rose 4.4 percent to $42.78. Enbridge and Spectra Energy agreed to merge in an all-stock transaction.
Sangamo Biosciences, Inc. SGMO shares gained 3.7 percent to $4.48 as the company disclosed that it has received orphan drug designation from the FDA for SB-FIX.